- Home
- HWBK vs TSHA Comparison
HWBK vs TSHA Comparison
Compare HWBK & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWBK
- TSHA
- Stock Information
- Founded
- HWBK 1865
- TSHA 2019
- Country
- HWBK United States
- TSHA United States
- Employees
- HWBK N/A
- TSHA N/A
- Industry
- HWBK Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- HWBK Finance
- TSHA Health Care
- Exchange
- HWBK Nasdaq
- TSHA Nasdaq
- Market Cap
- HWBK 242.4M
- TSHA 262.4M
- IPO Year
- HWBK N/A
- TSHA 2020
- Fundamental
- Price
- HWBK $29.20
- TSHA $1.24
- Analyst Decision
- HWBK
- TSHA Strong Buy
- Analyst Count
- HWBK 0
- TSHA 8
- Target Price
- HWBK N/A
- TSHA $6.63
- AVG Volume (30 Days)
- HWBK 17.1K
- TSHA 2.4M
- Earning Date
- HWBK 04-28-2025
- TSHA 05-13-2025
- Dividend Yield
- HWBK 2.60%
- TSHA N/A
- EPS Growth
- HWBK 1820.23
- TSHA N/A
- EPS
- HWBK 2.61
- TSHA N/A
- Revenue
- HWBK $71,882,000.00
- TSHA $8,333,000.00
- Revenue This Year
- HWBK N/A
- TSHA N/A
- Revenue Next Year
- HWBK N/A
- TSHA N/A
- P/E Ratio
- HWBK $11.20
- TSHA N/A
- Revenue Growth
- HWBK 36.16
- TSHA N/A
- 52 Week Low
- HWBK $17.86
- TSHA $1.05
- 52 Week High
- HWBK $35.95
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- HWBK 56.51
- TSHA 40.35
- Support Level
- HWBK $26.45
- TSHA $1.05
- Resistance Level
- HWBK $28.14
- TSHA $1.36
- Average True Range (ATR)
- HWBK 0.93
- TSHA 0.17
- MACD
- HWBK 0.32
- TSHA -0.01
- Stochastic Oscillator
- HWBK 90.31
- TSHA 25.68
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.